GATA3 siRNA inhibits the binding of NFAT1 to interleukin-13 promoter in human T cells

Chin Med J (Engl). 2010 Mar 20;123(6):739-44.

Abstract

Background: Interleukin-13 (IL-13) is recognized to be a key modulator in the pathogenesis of Th2-induced allergic inflammation. Transcription factors GATA3 and NFAT1 have been both implicated in the regulation of Th2 cytokines. We previously demonstrated the GATA3-NFAT1 association during human T cell activation. However, the function of the GATA3-NFAT1 complex in Th2 cytokines regulation is still unknown. Small interference RNA (siRNA) was constructed to knock down GATA3 expression in Hut-78 cells to investigate the possible role of GATA3-NFAT1 complex in IL-13 transcription.

Methods: Cells were stimulated with anti-CD3 plus anti-CD28 antibodies to mimic in vivo antigen-mediated co-stimulation; the expression of IL-13 mRNA was determined by real-time PCR; chromation immunoprecipitation (CHIP) assay was employed to investigate the NFAT1 binding to IL-13 promoter.

Results: GATA3 siRNA suppressed the expression of GATA3 both in mRNA and protein levels in Hut-78 cells. The binding of NFAT1 to IL-13 promoter was inhibited by GATA3 siRNA in activated T cells, which was followed by the reduction of IL-13 transcription.

Conclusion: GATA3-NFAT1 complex may play an important role in the regulation of IL-13 transcription in human T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • GATA3 Transcription Factor / antagonists & inhibitors*
  • GATA3 Transcription Factor / genetics
  • Humans
  • Interleukin-13 / genetics*
  • NFATC Transcription Factors / metabolism*
  • Promoter Regions, Genetic*
  • RNA, Small Interfering / genetics*
  • T-Lymphocytes / metabolism*
  • Transfection

Substances

  • GATA3 Transcription Factor
  • GATA3 protein, human
  • Interleukin-13
  • NFATC Transcription Factors
  • NFATC2 protein, human
  • RNA, Small Interfering